Eli Lilly's (LLY) fourth quarter and full-year earnings mostly met Wall Street estimates but missed expectations for sales of its weight loss GLP-1 drugs Mounjaro and Zepbound.

Given this perspective, it's time to examine the average forecasts of specific Lilly metrics that are routinely monitored and predicted by Wall Street analysts. Based on the collective assessment ...

Eli Lilly and Company LLY will release its fourth-quarter financial results, before the opening bell, on Thursday, Feb. 6, 2025. Analysts expect the Indianapolis, Indiana-based company to report ...

Eli Lilly's (LLY) fourth quarter and full-year earnings mostly met Wall Street estimates but missed expectations for sales of its weight loss GLP-1 drugs Mounjaro and Zepbound. Mizuho healthcare ...

Lawyers for the board that awards Pulitzer Prizes asked a Florida state court to pause the defamation lawsuit President Trump filed against board members in 2022 until Trump is no longer president.

The Pulitzer-prize winning writer ... and the Hill Art Foundation in Chelsea is hosting “The Writing’s on the Wall,” in which Als has assembled work by 32 artists, including Vija Celmins ...

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.

TALLAHASSEE — A Florida appeals court Wednesday cleared the way for President Donald Trump to pursue a defamation lawsuit against Pulitzer Prize board members in a dispute rooted in the ...

Mounjaro and Zepbound are by far Lilly's fastest-growing businesses, and the company's momentum in the GLP-1 realm seems to be the only thing Wall Street analysts are talking about these days.

The Pulitzer Prize-winning play “English” opened ... “I’m not here to say art can save us — but without art, we’re gonna die.” Also on the new episode of “Stagecraft,” Toossi ...